JERUSALEM--(BUSINESS WIRE)--May 15, 2014--
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) will host a live audio
webcast at the UBS Global Healthcare Conference. Eyal Desheh, EVP & CFO
will present on Monday, May 19, 2014 at 1:00 PM ET.
What: Teva Presentation at the UBS Global Healthcare Conference
Who: Eyal Desheh, EVP and CFO,
Teva Pharmaceutical Industries Ltd.
When: Monday, May 19, 2014
Where: www.tevapharm.com
How: Live over the Internet – log on to the Web at the address
above and register for the event (approximately 10 minutes before). An
archive of the webcast will be available on Teva’s website.
About Teva
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) is a leading global
pharmaceutical company, committed to increasing access to high-quality
healthcare by developing, producing and marketing affordable generic
drugs as well as innovative and specialty pharmaceuticals and active
pharmaceutical ingredients. Headquartered in Israel, Teva is the world's
leading generic drug maker, with a global product portfolio of more than
1,000 molecules and a direct presence in approximately 60 countries.
Teva's Specialty Medicines businesses focus on CNS, respiratory
oncology, pain, and women's health therapeutic areas as well as
biologics. Teva currently employs approximately 45,000 people around the
world and reached $20.3 billion in net revenues in 2013.
Source: Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.
IR:
United States
Kevin
C. Mannix, 215-591-8912
or
Ran Meir, 215-591-3033
or
Israel
Tomer
Amitai, 972 (3) 926-7656
or
PR:
Israel
Iris
Beck Codner, 972 (3) 926-7246
or
United States
Denise
Bradley, 215-591-8974